Cargando…
Cellular and Molecular Mediators of Intestinal Fibrosis
Intestinal fibrosis is a major complication of the inflammatory bowel diseases (IBD) and although inflammation is necessary for its development, it would appear that it plays a minor role in its progression as anti-inflammatory treatments in IBD do not prevent fibrosis once it has started. The proce...
Autores principales: | Lawrance, Ian C, Rogler, Gerhard, Bamias, Giorgos, Breynaert, Christine, Florholmen, Jon, Pellino, Gianluca, Reif, Shimon, Speca, Silvia, Latella, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885809/ https://www.ncbi.nlm.nih.gov/pubmed/25306501 http://dx.doi.org/10.1016/j.crohns.2014.09.008 |
Ejemplares similares
-
Interaction between sphingosine kinase/sphingosine 1 phosphate and transforming growth factor-β/Smads pathways in experimental intestinal fibrosis. An in vivo immunohistochemical study
por: Sferra, Roberta, et al.
Publicado: (2018) -
Could Pirfenidone Also be Effective in Treating Intestinal Fibrosis?
por: Latella, Giovanni, et al.
Publicado: (2020) -
Localization of αυβ6 Integrin-TGF-β1/Smad3, mTOR and PPARγ in Experimental Colorectal Fibrosis
por: Latella, G., et al.
Publicado: (2013) -
Hallmarks of epithelial to mesenchymal transition are detectable in Crohn’s disease associated intestinal fibrosis
por: Scharl, Michael, et al.
Publicado: (2015) -
Role of glycogen synthase kinase-3β and PPAR-γ on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis
por: Di Gregorio, Jacopo, et al.
Publicado: (2017)